2024 Q2 Form 10-Q Financial Statement

#000002523224000024 Filed on April 25, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $213.0M $209.2M
YoY Change 4.24% 3.21%
Cost Of Revenue $70.63M $71.08M
YoY Change 4.53% -0.19%
Gross Profit $142.3M $138.2M
YoY Change 4.09% 5.06%
Gross Profit Margin 66.84% 66.03%
Selling, General & Admin $9.058M $9.354M
YoY Change 10.73% 8.2%
% of Gross Profit 6.36% 6.77%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $95.42M $86.23M
YoY Change 18.87% 13.8%
% of Gross Profit 67.03% 62.41%
Operating Expenses $104.5M $95.58M
YoY Change 18.12% 13.23%
Operating Profit $141.3M $138.6M
YoY Change 192.6% 6.52%
Interest Expense $29.74M $28.91M
YoY Change -214.52% 15.49%
% of Operating Profit 21.05% 20.85%
Other Income/Expense, Net
YoY Change
Pretax Income $7.522M $13.10M
YoY Change -66.31% -39.57%
Income Tax
% Of Pretax Income
Net Earnings $7.840M $13.29M
YoY Change -65.34% -40.13%
Net Earnings / Revenue 3.68% 6.35%
Basic Earnings Per Share $0.05 $0.09
Diluted Earnings Per Share $0.05 $0.09
COMMON SHARES
Basic Shares Outstanding 152.1M shares 151.8M shares
Diluted Shares Outstanding 152.6M shares 152.4M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.954M $5.452M
YoY Change -25.86% 52.08%
Cash & Equivalents $5.954M $5.452M
Short-Term Investments
Other Short-Term Assets $14.36M $14.82M
YoY Change -13.7% 25.78%
Inventory
Prepaid Expenses
Receivables $16.35M $8.135M
Other Receivables $221.3M $217.9M
Total Short-Term Assets $257.9M $246.3M
YoY Change 10.47% 13.14%
LONG-TERM ASSETS
Property, Plant & Equipment $7.110B $7.102B
YoY Change 1.08% 0.97%
Goodwill $1.674M $1.674M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $160.9M $155.2M
YoY Change 15.74% 13.52%
Other Assets $73.22M $73.61M
YoY Change 8.73% 13.58%
Total Long-Term Assets $7.443B $7.437B
YoY Change 1.09% 0.97%
TOTAL ASSETS
Total Short-Term Assets $257.9M $246.3M
Total Long-Term Assets $7.443B $7.437B
Total Assets $7.701B $7.683B
YoY Change 1.38% 1.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $236.8M $216.8M
YoY Change -1.98% 5.74%
Accrued Expenses $49.90M $49.85M
YoY Change -6.42% -6.35%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $286.7M $266.6M
YoY Change -2.78% 3.25%
LONG-TERM LIABILITIES
Long-Term Debt $2.587B $2.563B
YoY Change 6.72% 4.67%
Other Long-Term Liabilities $349.6M $338.1M
YoY Change 28.14% 32.7%
Total Long-Term Liabilities $2.936B $2.901B
YoY Change 8.89% 7.31%
TOTAL LIABILITIES
Total Short-Term Liabilities $286.7M $266.6M
Total Long-Term Liabilities $2.936B $2.901B
Total Liabilities $3.223B $3.168B
YoY Change 6.92% 6.96%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $5.653B $5.648B
YoY Change -2.35% -2.37%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.454B $4.491B
YoY Change
Total Liabilities & Shareholders Equity $7.701B $7.683B
YoY Change 1.38% 1.32%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $7.840M $13.29M
YoY Change -65.34% -40.13%
Depreciation, Depletion And Amortization $95.42M $86.23M
YoY Change 18.87% 13.8%
Cash From Operating Activities $125.5M $28.29M
YoY Change -6.73% 6.79%
INVESTING ACTIVITIES
Capital Expenditures $91.45M $72.32M
YoY Change 41.96% 3.51%
Acquisitions
YoY Change
Other Investing Activities -$5.879M -$11.63M
YoY Change -168.42% -51.49%
Cash From Investing Activities -$97.32M -$83.95M
YoY Change 74.34% -10.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -27.69M $55.06M
YoY Change -62.74% -16.31%
NET CHANGE
Cash From Operating Activities 125.5M $28.29M
Cash From Investing Activities -97.32M -$83.95M
Cash From Financing Activities -27.69M $55.06M
Net Change In Cash 502.0K -$595.0K
YoY Change -88.71% -61.86%
FREE CASH FLOW
Cash From Operating Activities $125.5M $28.29M
Capital Expenditures $91.45M $72.32M
Free Cash Flow $34.07M -$44.03M
YoY Change -51.44% 1.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
8135000 usd
CY2023Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
11109000 usd
CY2024Q1 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
217926000 usd
CY2023Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
209370000 usd
CY2024Q1 us-gaap Equity Method Investments
EquityMethodInvestments
155210000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
143831000 usd
CY2024Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
105559000 usd
CY2023Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
110667000 usd
CY2024Q1 us-gaap Other Assets
OtherAssets
98761000 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
90745000 usd
CY2024Q1 us-gaap Assets
Assets
7682981000 usd
CY2023Q4 us-gaap Assets
Assets
7634474000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
2563332000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
2457627000 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
216790000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
299767000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
181744000 usd
CY2024Q1 cuz Intangible Liabilities
IntangibleLiabilities
40115000 usd
CY2023Q4 cuz Intangible Liabilities
IntangibleLiabilities
42193000 usd
CY2024Q1 us-gaap Other Liabilities
OtherLiabilities
102045000 usd
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
104830000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
3168021000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
3086161000 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
152071718 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
154335798 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
152071718 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
151799215 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
152072000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
154336000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5638709000 usd
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2536583 shares
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2192000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
4524151000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
24162000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4548313000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7634474000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
245739000 usd
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5496371000 usd
CY2023Q4 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
1125390000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
13451000 usd
CY2023Q1 cuz Amortization Of Stock Based Compensation Net Of Forfeitures
AmortizationOfStockBasedCompensationNetOfForfeitures
-3124000 usd
CY2023Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
738000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
165000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.32
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
48598000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4621036000 usd
CY2024Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
0 usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
145696000 usd
CY2024Q1 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
1160759000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3187000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
4490871000 usd
CY2024Q1 us-gaap Minority Interest
MinorityInterest
24089000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4514960000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7682981000 usd
CY2024Q1 us-gaap Revenues
Revenues
209241000 usd
CY2023Q1 us-gaap Revenues
Revenues
202728000 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
71075000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
71213000 usd
CY2024Q1 cuz Reimbursed Expenses
ReimbursedExpenses
140000 usd
CY2023Q1 cuz Reimbursed Expenses
ReimbursedExpenses
207000 usd
CY2024Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
9214000 usd
CY2023Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
8438000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
28908000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
25030000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
86230000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
75770000 usd
CY2024Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
672000 usd
CY2023Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
385000 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
196239000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
181043000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
348000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
673000 usd
CY2024Q1 us-gaap Gain Loss On Disposition Of Real Estate Discontinued Operations
GainLossOnDispositionOfRealEstateDiscontinuedOperations
101000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Real Estate Discontinued Operations
GainLossOnDispositionOfRealEstateDiscontinuedOperations
-2000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
13451000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
22356000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
163000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
160000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
13288000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
22196000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
151945000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
151579000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
152385000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
151880000 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
13288000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
22196000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
2705000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-1041000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
1710000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
189000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
995000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1230000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
14283000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
20966000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4548313000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
995000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-2812000 usd
CY2024Q1 cuz Amortization Of Stock Based Compensation Net Of Forfeitures
AmortizationOfStockBasedCompensationNetOfForfeitures
-3902000 usd
CY2024Q1 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
0 usd
CY2024Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
236000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.32
CY2024Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
48653000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4514960000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4646949000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
22356000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1230000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-2138000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
13451000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
22356000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
101000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-2000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
86230000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
75770000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1039000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1021000 usd
CY2024Q1 cuz Net Amortization Of Stock Options And Restricted Stock
NetAmortizationOfStockOptionsAndRestrictedStock
4338000 usd
CY2023Q1 cuz Net Amortization Of Stock Options And Restricted Stock
NetAmortizationOfStockOptionsAndRestrictedStock
3559000 usd
CY2024Q1 us-gaap Straight Line Rent
StraightLineRent
15984000 usd
CY2023Q1 us-gaap Straight Line Rent
StraightLineRent
11193000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
348000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
673000 usd
CY2024Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
787000 usd
CY2023Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
1299000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
5614000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
8407000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-55506000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-57240000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
28292000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
26494000 usd
CY2024Q1 cuz Payments To Acquire And Develop Real Estate And Tenant Asset Expenditures
PaymentsToAcquireAndDevelopRealEstateAndTenantAssetExpenditures
72317000 usd
CY2023Q1 cuz Payments To Acquire And Develop Real Estate And Tenant Asset Expenditures
PaymentsToAcquireAndDevelopRealEstateAndTenantAssetExpenditures
69863000 usd
CY2024Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
11634000 usd
CY2023Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
23984000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-83951000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-93847000 usd
CY2024Q1 us-gaap Proceeds From Unsecured Lines Of Credit
ProceedsFromUnsecuredLinesOfCredit
171200000 usd
CY2023Q1 us-gaap Proceeds From Unsecured Lines Of Credit
ProceedsFromUnsecuredLinesOfCredit
165000000 usd
CY2024Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
64100000 usd
CY2023Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
49300000 usd
CY2024Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
2113000 usd
CY2023Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
2041000 usd
CY2024Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 usd
CY2023Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
32000 usd
CY2024Q1 cuz Repurchase Of Shares Withheld For Taxes On Restricted Stock Vestings
RepurchaseOfSharesWithheldForTaxesOnRestrictedStockVestings
1111000 usd
CY2023Q1 cuz Repurchase Of Shares Withheld For Taxes On Restricted Stock Vestings
RepurchaseOfSharesWithheldForTaxesOnRestrictedStockVestings
0 usd
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
48576000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
48407000 usd
CY2024Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
0 usd
CY2023Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
738000 usd
CY2024Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
236000 usd
CY2023Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
165000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
55064000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
65793000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-595000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1560000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6047000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5145000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5452000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3585000 usd
CY2024Q1 cuz Distribution Of Taxable Income To Qualify As Reit Minimum
DistributionOfTaxableIncomeToQualifyAsREITMinimum
1
CY2024Q1 cuz Companys Portfolio Of Real Estate Assets Consist Office Space
CompanysPortfolioOfRealEstateAssetsConsistOfficeSpace
18800000 sqft
CY2024Q1 cuz Companys Portfolio Of Real Estate Assets Consist Retail Space
CompanysPortfolioOfRealEstateAssetsConsistRetailSpace
310000 sqft
CY2024Q1 us-gaap Goodwill
Goodwill
1674000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
1674000 usd
CY2024Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
105559000 usd
CY2023Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
110667000 usd
CY2024Q1 cuz Predevelopment Costs
PredevelopmentCosts
57394000 usd
CY2023Q4 cuz Predevelopment Costs
PredevelopmentCosts
56600000 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14818000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8704000 usd
CY2024Q1 cuz Accumulated Amortization Incentives To Lessees
AccumulatedAmortizationIncentivesToLessees
6460000 usd
CY2023Q4 cuz Accumulated Amortization Incentives To Lessees
AccumulatedAmortizationIncentivesToLessees
5860000 usd
CY2024Q1 us-gaap Incentive To Lessee
IncentiveToLessee
12254000 usd
CY2023Q4 us-gaap Incentive To Lessee
IncentiveToLessee
10537000 usd
CY2024Q1 cuz Furniture Fixture And Equipment And Leasehold Improvements Accumulated Depreciation
FurnitureFixtureAndEquipmentAndLeaseholdImprovementsAccumulatedDepreciation
18937000 usd
CY2023Q4 cuz Furniture Fixture And Equipment And Leasehold Improvements Accumulated Depreciation
FurnitureFixtureAndEquipmentAndLeaseholdImprovementsAccumulatedDepreciation
18564000 usd
CY2024Q1 cuz Furniture Fixture And Equipment And Leasehold Improvements
FurnitureFixtureAndEquipmentAndLeaseholdImprovements
10331000 usd
CY2023Q4 cuz Furniture Fixture And Equipment And Leasehold Improvements
FurnitureFixtureAndEquipmentAndLeaseholdImprovements
10631000 usd
CY2024Q1 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
2452000 usd
CY2023Q4 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
2131000 usd
CY2024Q1 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
3964000 usd
CY2023Q4 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
4273000 usd
CY2024Q1 us-gaap Other Assets
OtherAssets
98761000 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
90745000 usd
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2567055000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2462068000 usd
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
3723000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
4441000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
2563332000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
2457627000 usd
CY2024Q1 cuz Debt Instrument Weighted Average Maturity Period
DebtInstrumentWeightedAverageMaturityPeriod
P2Y9M18D
CY2024Q1 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
2500000000 usd
CY2023Q4 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
2400000000 usd
CY2024Q1 us-gaap Interest Costs Incurred
InterestCostsIncurred
32614000 usd
CY2023Q1 us-gaap Interest Costs Incurred
InterestCostsIncurred
30121000 usd
CY2024Q1 us-gaap Interest Costs Incurred Capitalized
InterestCostsIncurredCapitalized
3706000 usd
CY2023Q1 us-gaap Interest Costs Incurred Capitalized
InterestCostsIncurredCapitalized
5091000 usd
CY2024Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
28908000 usd
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
25030000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
2705000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-1041000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
1710000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
189000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
28908000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
25030000 usd
CY2024Q1 us-gaap Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months
CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
3200000 usd
CY2024Q1 cuz Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
49846000 usd
CY2023Q4 cuz Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
53348000 usd
CY2024Q1 us-gaap Advance Rent
AdvanceRent
34566000 usd
CY2023Q4 us-gaap Advance Rent
AdvanceRent
34872000 usd
CY2024Q1 us-gaap Lease Deposit Liability
LeaseDepositLiability
15804000 usd
CY2023Q4 us-gaap Lease Deposit Liability
LeaseDepositLiability
15050000 usd
CY2024Q1 us-gaap Other Sundry Liabilities
OtherSundryLiabilities
1829000 usd
CY2023Q4 us-gaap Other Sundry Liabilities
OtherSundryLiabilities
1560000 usd
CY2024Q1 us-gaap Other Liabilities
OtherLiabilities
102045000 usd
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
104830000 usd
CY2024Q1 cuz Outstanding Performance Bonds
OutstandingPerformanceBonds
1100000 usd
CY2024Q1 cuz Outstanding Commitments To Fund Real Estate Projects
OutstandingCommitmentsToFundRealEstateProjects
111300000 usd
CY2021Q3 cuz Sale Of Stock Number Of Participating Financial Institutions
SaleOfStockNumberOfParticipatingFinancialInstitutions
6 financial_institution
CY2024Q1 us-gaap Treasury Stock Shares Retired
TreasuryStockSharesRetired
2536583 shares
CY2024Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
57.44
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4318000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3572000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
13451000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
22356000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
13288000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
22196000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
151945000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
151579000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2024Q1 us-gaap Profit Loss
ProfitLoss
13451000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
22356000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
13290000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
22200000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
151945000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
151579000 shares
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
25000 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
25000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
152385000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
151880000 shares
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
37331000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
33219000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2024Q1 cuz Retirement Of Treasury Stock
RetirementOfTreasuryStock
145696000 usd
CY2023Q1 cuz Retirement Of Treasury Stock
RetirementOfTreasuryStock
0 usd
CY2024Q1 cuz Tenant Improvements Funded By Tenants
TenantImprovementsFundedByTenants
66427000 usd
CY2023Q1 cuz Tenant Improvements Funded By Tenants
TenantImprovementsFundedByTenants
26943000 usd
CY2024Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
48653000 usd
CY2023Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
48600000 usd
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
87254000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
85399000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
138625000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
130136000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
13451000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
22356000 usd
CY2024Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
9214000 usd
CY2023Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
8438000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
28908000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
25030000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
86230000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
75770000 usd
CY2024Q1 cuz Reimbursed Expenses
ReimbursedExpenses
140000 usd
CY2023Q1 cuz Reimbursed Expenses
ReimbursedExpenses
207000 usd
CY2024Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
672000 usd
CY2023Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
385000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
348000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
673000 usd
CY2024Q1 cuz Net Operating Income From Unconsolidated Joint Ventures
NetOperatingIncomeFromUnconsolidatedJointVentures
1352000 usd
CY2023Q1 cuz Net Operating Income From Unconsolidated Joint Ventures
NetOperatingIncomeFromUnconsolidatedJointVentures
1409000 usd
CY2024Q1 us-gaap Gain Loss On Disposition Of Real Estate Discontinued Operations
GainLossOnDispositionOfRealEstateDiscontinuedOperations
101000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Real Estate Discontinued Operations
GainLossOnDispositionOfRealEstateDiscontinuedOperations
-2000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
138625000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
130136000 usd

Files In Submission

Name View Source Status
0000025232-24-000024-index-headers.html Edgar Link pending
0000025232-24-000024-index.html Edgar Link pending
0000025232-24-000024.txt Edgar Link pending
0000025232-24-000024-xbrl.zip Edgar Link pending
cuz-20240331.htm Edgar Link pending
cuz-20240331.xsd Edgar Link pending
cuz-exhibit3111q24.htm Edgar Link pending
cuz-exhibit3121q24.htm Edgar Link pending
cuz-exhibit3211q24.htm Edgar Link pending
cuz-exhibit3221q24.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
cuz-20240331_def.xml Edgar Link unprocessable
cuz-20240331_lab.xml Edgar Link unprocessable
cuz-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cuz-20240331_htm.xml Edgar Link completed
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cuz-20240331_cal.xml Edgar Link unprocessable